CD8A and common variable immunodeficiency: Interestingly, in CVID, lower anti-SARS-CoV-2 IgG levels were observed in those receiving higher monthly immunoglobulin doses and characterized by an increased percentage of B cells and CD8+ T-cells in the lymphocyte subpopulations.